1
/
of
0
FDA Drug Approval, N011459, VISTARIL
FDA Drug Approval, N011459, VISTARIL
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 011459
Company: PFIZER
Drug Name: VISTARIL
Active Ingredients: HYDROXYZINE PAMOATE
Strength: EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: CAPSULE;ORAL
Action Date: 11/15/1968
Marketing Status: Discontinued
Submission Classification: Type 2 - New Active Ingredient
Company: PFIZER
Drug Name: VISTARIL
Active Ingredients: HYDROXYZINE PAMOATE
Strength: EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form/Route: CAPSULE;ORAL
Action Date: 11/15/1968
Marketing Status: Discontinued
Submission Classification: Type 2 - New Active Ingredient
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details